BioCatalystWatch
CRDLWorkspace / CRDL / OverviewCompany library
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. (CRDL)

Website

Price
Market cap
Next catalystExpected 2H 2027CRD-38 — subcutaneous formulation · Study completionSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

CRD-38

Small molecule

Upcoming / outlook

CardiolRx

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CardiolRx

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

CRD-38

Small molecule

Upcoming / outlook

Other pipelines

History / paused

CardiolRx

Small molecule

PreINDP1P2P3FilingApproved
CardiolRx

Small molecule

PreINDP1P2P3FilingApproved
CardiolRx

Small molecule

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CRDL PR & News

PR & News

CRDL SEC archive